Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics

• François Autelitano ,

  * E-mail: francois.autelitano@sanofi.com

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Denis Loyaux,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Sébastien Roudières,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Catherine Déon,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Frédérique Guette,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Philippe Fabre,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Qinggong Ping,

  Affiliation ALS Therapy Development Institute, Cambridge, Massachusetts, United States of America

  ⨯
• Su Wang,

  Affiliation Department of Neurology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Romane Auvergne,

  Affiliation Department of Neurology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Vasudeo Badarinarayana,

  Affiliation Sanofi Tucson Research Center, Oro Valley, Arizona, United States of America

  ⨯
• Michael Smith,

  Affiliation Sanofi Tucson Research Center, Oro Valley, Arizona, United States of America

  ⨯
• Jean-Claude Guillemot,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
• Steven A. Goldman,

  Affiliation Department of Neurology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Sridaran Natesan,

  Affiliation Sanofi US, Cambridge, Massachusetts, United States of America

  ⨯
• Pascual Ferrara,

  Affiliation Sanofi-Aventis Recherche & Développement, Centre de Toulouse, Toulouse, France

  ⨯
•  [ ... ],
• Paul August

  Affiliation Sanofi Tucson Research Center, Oro Valley, Arizona, United States of America

  ⨯
• [ view all ]
• [ view less ]